Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

Oral Minoxidil can cause serious eye problems, but stopping it can improve vision.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Bariatric surgery can cause serious mineral deficiencies, requiring better patient education and monitoring.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Microneedles are effective for drug delivery, vaccinations, fluid extraction, and treating hair loss, with advancements in manufacturing like 3D printing.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

Testosterone's effects on COVID-19 are unclear and need more research.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Common skin conditions can greatly affect a person's mental health and social life.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.